Description of Collaborative Activity: |
Six National Institutes of Health (NIH) institutes and the Food and Drug Administration (FDA) are participating in a multi-year National Academy of Medicine (NAM)-led activity entitled "Forum on Regenerative Medicine". The objective of the Forum is to engage key stakeholders of regenerative medicine in a dialogue about opportunities and challenges facing translation of regenerative medicine science and technologies to the clinic. The setting of the NAM provides a neutral convening mechanism for interactions between academia, industry, government, regulators, patients’ organizations, foundations, and others. In addition to science, ethical, legal, and societal issues related to regenerative
medicine are discussed. In October 2016 the Forum supported a highly successful interdisciplinary workshop that examined the current state of science in regenerative medicine. Further activities are currently being planned. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
NIH Participating Institutes/Centers/Office of the Director: |
NHLBI, NIAMS, NIBIB, NIDCR, NIDDK, NINDS |
